LIQUIDIA TECHNOLOGIES INC
Profile
Company Names
LIQUIDIA TECHNOLOGIES INC
Addresses
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC 27560
419 DAVIS DRIVE, SUITE 100, DURHAM, NC 27713
Phone Numbers
919-328-4400
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, OTHER
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$86,724,995.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2019-12-23
$22,424,991.00
$22,424,991.00
$0.00
Equity
3
2018-02-02
$25,500,000.00
$53,312,680.00
$27,812,680.00
Equity
2
2011-02-18
$13,799,994.00
$13,799,994.00
$0.00
Equity
1
2009-07-01
$25,000,010.00
$25,000,010.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEPHEN
BLOCH
DIRECTOR
VIACOR INC
| MARINUS PHARMACEUTICALS INC
| LIQUIDIA TECHNOLOGIES INC
| DICOM GRID INC
| AXIAL EXCHANGE, INC.
| ENVISIA THERAPEUTICS INC.
| LQ3 PHARMACEUTICALS, INC.
| ENVISIA THERAPEUTICS, INC.
| SAMPLE6, INC.
| GENOME MEDICAL HOLDING CO
| CORVIUM, INC.
| ONKOS SURGICAL, INC.
| EVOLVEIMMUNE THERAPEUTICS HOLDING COMPANY, LLC
| IANTREK, INC.
| LIQUIDIA CORP
| ALLYX THERAPEUTICS, INC.
| THYRON PHARMACEUTICALS, INC.
ISAAC
CHENG
DIRECTOR
LIQUIDIA TECHNOLOGIES INC
| BIOSCALE INC
| EDISON PHARMACEUTICALS INC
| ATREAON, INC.
| SYNCHRONEURON INC.
| AMYLYX PHARMACEUTICALS, INC.
| TORPEDO DIAGNOSTICS, INC.
| DNATRIX INC
| ADJUVANCE TECHNOLOGIES INC.
| INCARDA THERAPEUTICS, INC.
| MEISSA VACCINES INC
| TALLAC THERAPEUTICS, INC.
| APNIMED, INC.
| MEDRHYTHMS, INC.
JOSEPH
DESIMONE
DIRECTOR
NEAL
FOWLER
EXECUTIVE OFFICER, DIRECTOR
KEVIN
GORDON
EXECUTIVE OFFICER
ED
MATHERS
DIRECTOR
LIQUIDIA TECHNOLOGIES INC
| INTARCIA THERAPEUTICS, INC
| ENVISIA THERAPEUTICS INC.
| SYNLOGIC, INC.
| MIRNA THERAPEUTICS, INC.
| AMPLYX PHARMACEUTICALS, INC.
| ENVISIA THERAPEUTICS, INC.
| SYNLOGIC, LLC
| TREVI THERAPEUTICS, INC.
| AKOUOS, INC.
| RENEO PHARMACEUTICALS, INC.
| SENTI BIOSCIENCES, INC.
| MIRUM PHARMACEUTICALS, INC.
| CURZION PHARMACEUTICALS, INC.
EDWARD
MATHERS
DIRECTOR
RA PHARMACEUTICALS, INC.
| RHYTHM PHARMACEUTICALS, INC.
| SATORI PHARMACEUTICALS INC
| MIRNA THERAPEUTICS, INC.
| RHYTHM HOLDING COMPANY, LLC
| LUMENA PHARMACEUTICALS, INC.
| LUMOS PHARMA, INC.
| AMPLYX PHARMACEUTICALS, INC.
| LIQUIDIA TECHNOLOGIES INC
| INOZYME PHARMA, INC.
| SYNLOGIC, INC.
| AFFINIA THERAPEUTICS INC.
| CODE BIOTHERAPEUTICS, INC.
| TREVI THERAPEUTICS, INC.
| SORRISO PHARMACEUTICALS, INC.
| MBX BIOSCIENCES, INC.
| CARDURION PHARMACEUTICALS, INC.
| BRENIG THERAPEUTICS, INC.
| SENTI BIOSCIENCES, INC.
| SENTI BIOSCIENCES HOLDINGS, INC.
| SENTI HOLDINGS, INC.
| SENTI BIOSCIENCES, INC.
STEVE
NELSON
DIRECTOR
SETH
RUDNICK
DIRECTOR
RALPH
SNYDERMAN
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841]
DECLINE TO DISCLOSE
Equity
2019-12-23
D
BIOTECHNOLOGY
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841]
$5,000,001 - $25,000,000
Equity
2018-02-02
